Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid
Clinical trial NCT04736043 · UNKNOWN
Trial details
- NCT number
- NCT04736043
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-31
- Primary completion
- 2025-01-07
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.